Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Nation

Showing results (151-160 of 247) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|January 9, 2008
Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimensStephanie J Wallace, Jian Li, Roger L Nation, et al.
Critical Reviews in Microbiology|June 27, 2013
Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysisSiow Chin Heng, Orla Morrissey, Sharon C-A Chen, et al.
Antimicrobial Agents and Chemotherapy|November 6, 2013
Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysisPornpan Koomanachai, Cornelia B Landersdorfer, Gong Chen, et al.
Pharmacotherapy|January 30, 2015
Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale usePhillip J Bergen, Zackery P Bulman, Sarith Saju, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2015
Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutatorsZackery P Bulman, Mark D Sutton, Neang S Ly, et al.
The Journal of Antimicrobial Chemotherapy|February 21, 2015
Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosingAnupop Jitmuang, Roger L Nation, Pornpan Koomanachai, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2013
Polymyxin B Induces Apoptosis in Kidney Proximal Tubular CellsMohammad A K Azad, Ben A Finnin, Anima Poudyal, et al.
Biochemical Pharmacology|May 17, 2012
Structure-activity relationships for the binding of polymyxins with human α-1-acid glycoproteinMohammad A K Azad, Johnny X Huang, Matthew A Cooper, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2017
Methionine Ameliorates Polymyxin-Induced Nephrotoxicity by Attenuating Cellular Oxidative StressMohammad A K Azad, Sivashangarie Sivanesan, Jiping Wang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 31, 2025
Disposition of colistin in critically-ill patients on sustained low-efficiency dialysis: A population pharmacokinetic studyAdhiratha Boonyasiri, Dominika T Fuhs, Thummaporn Naorungroj, et al.
Pageof 25

Showing results (151-160 of 247) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|January 9, 2008
Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimensStephanie J Wallace, Jian Li, Roger L Nation, et al.
Critical Reviews in Microbiology|June 27, 2013
Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysisSiow Chin Heng, Orla Morrissey, Sharon C-A Chen, et al.
Antimicrobial Agents and Chemotherapy|November 6, 2013
Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysisPornpan Koomanachai, Cornelia B Landersdorfer, Gong Chen, et al.
Pharmacotherapy|January 30, 2015
Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale usePhillip J Bergen, Zackery P Bulman, Sarith Saju, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2015
Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutatorsZackery P Bulman, Mark D Sutton, Neang S Ly, et al.
The Journal of Antimicrobial Chemotherapy|February 21, 2015
Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosingAnupop Jitmuang, Roger L Nation, Pornpan Koomanachai, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2013
Polymyxin B Induces Apoptosis in Kidney Proximal Tubular CellsMohammad A K Azad, Ben A Finnin, Anima Poudyal, et al.
Biochemical Pharmacology|May 17, 2012
Structure-activity relationships for the binding of polymyxins with human α-1-acid glycoproteinMohammad A K Azad, Johnny X Huang, Matthew A Cooper, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2017
Methionine Ameliorates Polymyxin-Induced Nephrotoxicity by Attenuating Cellular Oxidative StressMohammad A K Azad, Sivashangarie Sivanesan, Jiping Wang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 31, 2025
Disposition of colistin in critically-ill patients on sustained low-efficiency dialysis: A population pharmacokinetic studyAdhiratha Boonyasiri, Dominika T Fuhs, Thummaporn Naorungroj, et al.
Pageof 25